Navigation Links
IntegriChain Delivers Pharmacy Level Inventory Metrics

PRINCETON, N.J., Feb. 15, 2012 /PRNewswire/ -- IntegriChain Inc., a commercial provider of data and analytic insights to the pharmaceutical industry, announced today the introduction of a new methodology for its DNA: Inventory – Retail solution that adds the ability to report on independent and chain pharmacies' inventory levels, by product NDC code, using actual un-projected data.


Historically, manufacturers have had visibility to wholesaler inventory and a handful of chain warehouses, but no way to directly measure inventory in the overall retail channel.

IntegriChain's new methodology uses a combination of product "sell-in" data, product "returns" data, and actual pharmacy "point-of-sale" data to accurately calculate inventory levels in the downstream retail channel.    

"The ability to align actual pharmacy purchases, sales and returns enables us to deliver a complete and timely view of inventory trends for our customers," said Kevin Leininger, IntegriChain CEO.  "Finance, forecasters and demand planners need forward channel visibility now more than ever.  With blockbuster patent expirations and mounting supply shortages, retail inventory is key to sound business planning."

Through the DNA Inventory: Retail solution, IntegriChain is now able to report an NDC's total units, dollars and days of inventory present in retail distribution centers, stores, and morgues on a weekly basis. 

According to Dan Kinney, IntegriChain VP of Information Services, IntegriChain customers are using DNA Inventory to "tighten their pipeline inventory reserves and improve their demand planning efficiency.  The bottom line is to fill the highest possible percentage of orders while not tying up undue amounts of capital on the balance sheet."

About IntegriChain
IntegriChain, Inc. is a next-generation life sciences informatics company.  IntegriChain's industry leading platform for channel data integration and enrichment delivers pharmaceutical and biotech manufacturers marketplace insight with unprecedented speed and transparency.  Located in Princeton, New Jersey, IntegriChain is a recent recipient of the Inc 500, Red Herring 100 New Jersey Technology Council's Early Stage Company of the Year and the Forbes list of America's Most Promising Companies.

Contact: Ric Padron

IntegriChain, Inc.

Phone: 609.986.2004

Fax: 609.806.5006


100 Canal Pointe Blvd.

Suite 110

Princeton, NJ 08540


SOURCE IntegriChain, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Forbes Announces IntegriChain in Top 20 on List of Americas Most Promising Companies
2. IntegriChain Launches DNA: Dynamic NextGen Analytics(TM) Platform
3. Excellence Services Program Delivers a Road Map to Successfully Guide the Pharmaceutical Industry Through the New Alliance Landscape
4. China Health Resource CEO Delivers Speech at 10th Year Anniversary Celebration
5. Everist Genomics to Launch CardioDefender: Worlds Only Mobile ECG System that Delivers Real-time, Beat-by-beat, Quantitative Heart Monitoring Data to Physicians
6. Mevion Medical Systems Delivers the Worlds First Superconducting Synchrocyclotron for Proton Therapy to Barnes Jewish Hospital
7. BT Delivers Vision of Intelligent Supply Chain at LogiPharma Conference
8. Next Generation of TrackWise® Enterprise Quality Management Software Delivers Enhanced Web Services Functionality for Global Organizations
9. AccuNurse Delivers Real-Time Care Plan Functionality and New Dashboard to Monitor Clinical Trends, Performance and Compliance
10. Microsemi Delivers New Voltage Suppression Solutions for Magnetic Environments
11. SpaCapsule Manufacturer Delivers First Order to Elements Diet and Fitness Under Preferred Vendor Agreement
Post Your Comments:
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... November 29, 2015 , ... ProStatic Analog Distortion ... tool designed specially for Final Cut Pro X. FCPX users can ... easy-to-use modification controls. Destoying and creating chaotic distortion is now quick and simple, ...
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can actually ... conceived of this design due to personal experience with a bad back," he said. ... and convenience, as well as increases support. It also makes it easier to eat, ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... study carried out by the University of Toronto and the University of British Columbia ... of hospitalizations for head injuries. The article explains that part of the reason for ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I ... an inventor from Hillside, N.J. "Many people catch diseases simply from sitting on ... will always be protected from germs." , He developed the patent-pending QUDRATECS to ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... progress through sharing, the 2016 Building Better Radiology Marketing Programs meeting ... begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas with ...
Breaking Medicine News(10 mins):